TherapeuticsMD (TXMD) Current Assets (2010 - 2026)

TherapeuticsMD (TXMD) has reported Current Assets for 17 consecutive years, with $16.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 19.76% year-over-year to $16.1 million; the trailing twelve-month figure through Jun 2026 stood at $16.1 million (up 19.76% YoY), and the FY2025 full-year result was $14.4 million, up 17.83% from the prior year.
• Current Assets improved to $16.1 million in Q2 2026 per TXMD's latest filing, from $15.3 million in the prior quarter.
• Across five years, Current Assets topped out at $98.6 million in Q2 2022 and bottomed at $11.5 million in Q1 2024.
• Historically, Current Assets has averaged $29.6 million across 5 years, with a median of $14.9 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Current Assets tumbled 80.11% in 2023, then climbed 21.99% in 2026.
• Over 5 years, Current Assets stood at $55.4 million in 2022, then slumped by 78.69% to $11.8 million in 2023, then climbed by 3.93% to $12.3 million in 2024, then gained by 17.83% to $14.4 million in 2025, then rose by 11.6% to $16.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $16.1 million, $15.3 million, and $14.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.